Clinical trials: Allergic Reaction to Nickel

Dermatitis, Allergic Contact

CP-481,715 Nickel Allergy Study.

• Completed
• Age: 18 to 55 years
• Phase 1

To evaluate the suitability of contact allergy as a method for the evaluation of c-chemokine receptor-1 antagonist.

Trial name

NCT00141180

Testing

CP-481,715

Where

5 sites in United States, Denmark

Volunteers

48 people, healthy volunteers welcome

Sponsor

Pfizer